Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Catalyst Capital Advisors LLC

Catalyst Capital Advisors LLC lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3,071.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,027 shares of the company's stock after purchasing an additional 22,301 shares during the period. Catalyst Capital Advisors LLC's holdings in Cardinal Health were worth $3,172,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. IFM Investors Pty Ltd increased its stake in shares of Cardinal Health by 28.5% in the first quarter. IFM Investors Pty Ltd now owns 45,692 shares of the company's stock worth $6,295,000 after buying an additional 10,122 shares during the last quarter. OneDigital Investment Advisors LLC increased its stake in shares of Cardinal Health by 13.6% in the first quarter. OneDigital Investment Advisors LLC now owns 4,273 shares of the company's stock worth $589,000 after buying an additional 512 shares during the last quarter. 44 Wealth Management LLC increased its stake in shares of Cardinal Health by 7.3% in the first quarter. 44 Wealth Management LLC now owns 19,286 shares of the company's stock worth $2,657,000 after buying an additional 1,304 shares during the last quarter. Silver Oak Securities Incorporated bought a new stake in shares of Cardinal Health in the first quarter worth $211,000. Finally, Conning Inc. bought a new stake in shares of Cardinal Health in the first quarter worth $212,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of CAH traded up $2.69 during midday trading on Monday, hitting $167.62. 1,910,305 shares of the stock traded hands, compared to its average volume of 2,244,927. The firm has a market capitalization of $40.01 billion, a PE ratio of 26.15, a price-to-earnings-growth ratio of 1.63 and a beta of 0.68. The business's 50 day moving average price is $156.17 and its two-hundred day moving average price is $137.79. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. The company's quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.08 earnings per share. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.22%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date is Tuesday, July 1st. Cardinal Health's dividend payout ratio is presently 31.83%.

Analysts Set New Price Targets

CAH has been the subject of a number of research analyst reports. UBS Group lifted their price target on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Morgan Stanley set a $181.00 price target on shares of Cardinal Health and gave the stock an "overweight" rating in a research note on Friday, June 13th. Mizuho lifted their price target on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research note on Monday, March 31st. Robert W. Baird boosted their target price on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. Finally, Evercore ISI reiterated an "outperform" rating and set a $180.00 target price (up previously from $175.00) on shares of Cardinal Health in a research note on Thursday, June 12th. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Cardinal Health currently has an average rating of "Moderate Buy" and an average target price of $157.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.